IL85983A - Human somatomedin carrier protein subunits, antibodies against them, pharmaceutical compostitions containing them and their use in the preparation of medicaments - Google Patents

Human somatomedin carrier protein subunits, antibodies against them, pharmaceutical compostitions containing them and their use in the preparation of medicaments

Info

Publication number
IL85983A
IL85983A IL8598388A IL8598388A IL85983A IL 85983 A IL85983 A IL 85983A IL 8598388 A IL8598388 A IL 8598388A IL 8598388 A IL8598388 A IL 8598388A IL 85983 A IL85983 A IL 85983A
Authority
IL
Israel
Prior art keywords
carrier protein
human
growth
polypeptide
somatomedins
Prior art date
Application number
IL8598388A
Other languages
English (en)
Other versions
IL85983A0 (en
Original Assignee
Celtrix Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Celtrix Pharma filed Critical Celtrix Pharma
Publication of IL85983A0 publication Critical patent/IL85983A0/xx
Publication of IL85983A publication Critical patent/IL85983A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4743—Insulin-like growth factor binding protein
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Dermatology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
IL8598388A 1987-04-06 1988-04-05 Human somatomedin carrier protein subunits, antibodies against them, pharmaceutical compostitions containing them and their use in the preparation of medicaments IL85983A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US3488587A 1987-04-06 1987-04-06

Publications (2)

Publication Number Publication Date
IL85983A0 IL85983A0 (en) 1988-09-30
IL85983A true IL85983A (en) 1994-10-07

Family

ID=21879212

Family Applications (1)

Application Number Title Priority Date Filing Date
IL8598388A IL85983A (en) 1987-04-06 1988-04-05 Human somatomedin carrier protein subunits, antibodies against them, pharmaceutical compostitions containing them and their use in the preparation of medicaments

Country Status (11)

Country Link
EP (2) EP0308500B1 (da)
JP (1) JP2648951B2 (da)
AT (1) ATE90690T1 (da)
AU (1) AU627423B2 (da)
CA (1) CA1340295C (da)
DE (1) DE3881801T2 (da)
DK (1) DK677688A (da)
ES (1) ES2058341T3 (da)
IL (1) IL85983A (da)
WO (1) WO1988007863A1 (da)
ZA (1) ZA882407B (da)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5973115A (en) * 1987-05-15 1999-10-26 Amgen Inc. Method for potentiating and inhibiting insulin-like growth factor activity
US5258287A (en) * 1988-03-22 1993-11-02 Genentech, Inc. DNA encoding and methods of production of insulin-like growth factor binding protein BP53
AU1955388A (en) * 1988-04-12 1989-11-03 Synergen, Inc. Method for potentiating and inhibiting insulin-like growth factor activity
US6465423B1 (en) 1988-07-15 2002-10-15 Central Sydney Area Health Service Acid-labile subunit (ALS) of insulin-like growth factor binding protein complex
US5324820A (en) * 1988-07-15 1994-06-28 Central Sydney Area Health Service Acid-labile subunit (ALS) of insulin-like growth factor binding protein complex
CA1341598C (en) * 1988-07-15 2009-09-29 Central Sydney Area Health Service Acid-labile sub-unit (als) of insulin-like growth factor binding proteincomplex
US5187151A (en) * 1991-02-12 1993-02-16 Genentech, Inc. Use of binding protein with igf-i as an anabolic growth promoting agent
CA2195474A1 (en) * 1994-07-20 1996-02-01 Cedo Martin Bagi Igf/igfbp complex for promoting bone formation and for regulating bone remodeling
US6420518B1 (en) 1997-04-04 2002-07-16 Genetech, Inc. Insulin-like growth factor agonist molecules
US6121416A (en) 1997-04-04 2000-09-19 Genentech, Inc. Insulin-like growth factor agonist molecules
WO2000040612A1 (en) 1999-01-06 2000-07-13 Genentech, Inc. Insulin-like growth factor (igf) i mutant variants
DE60016560T2 (de) 1999-01-06 2005-12-15 Genentech, Inc., South San Francisco Mutierte variante des insulin-ähnlichen wachstumsfaktor-i (igf-i)
DK1282437T3 (da) 2000-05-16 2008-06-30 Genentech Inc Behandling af brusklidelser
AU2002248609B2 (en) 2001-03-14 2007-03-01 Genentech, Inc. IGF antagonist peptides
JP2007535895A (ja) 2003-05-01 2007-12-13 イムクローン システムズ インコーポレイティド ヒトインシュリン様成長因子−１受容体に対する完全ヒト抗体
CN102861321A (zh) 2003-09-12 2013-01-09 特西卡股份有限公司 胰岛素样生长因子-1(igf-1)缺陷的治疗方法
WO2005033132A2 (en) 2003-10-03 2005-04-14 Genentech, Inc. Igf binding proteins
BRPI0611984A2 (pt) 2005-06-17 2009-07-07 Imclone Systems Inc uso de anticorpos igf-ir para fabricação de um medicamento para tratar um tumor ósseo
WO2007092453A2 (en) 2006-02-03 2007-08-16 Imclone Systems Incorporated Igf-ir antagonists as adjuvants for treatment of prostate cancer
PE20201166A1 (es) 2017-09-11 2020-10-28 Shire Human Genetic Therapies Metodos y composiciones para tratar enfermedades pulmonares cronicas
TW202233228A (zh) 2020-10-19 2022-09-01 美商舒爾人類基因療法公司 適用於新生兒的組成物
CN118574840A (zh) 2022-01-19 2024-08-30 奥克希尔生物有限公司 用于减少igf-1/igfbp的氧化的组合物和方法
WO2023242439A1 (en) 2022-06-17 2023-12-21 Oak Hill Bio Limited Vascular stabilisation (preterm infants)
WO2023242440A1 (en) 2022-06-17 2023-12-21 Oak Hill Bio Limited Treament of lungs in infants
WO2023242442A1 (en) 2022-06-17 2023-12-21 Oak Hill Bio Limited Method of maturing/differentiating neurons and/or modulating the vagus nerve
WO2024170612A1 (en) 2023-02-14 2024-08-22 Oak Hill Bio Limited Treatment of healing dysregulation in gi tissue

Also Published As

Publication number Publication date
EP0308500A1 (en) 1989-03-29
DK677688D0 (da) 1988-12-05
EP0308500B1 (en) 1993-06-16
DK677688A (da) 1988-12-05
ATE90690T1 (de) 1993-07-15
CA1340295C (en) 1998-12-29
DE3881801D1 (de) 1993-07-22
AU627423B2 (en) 1992-08-27
DE3881801T2 (de) 1993-12-23
ES2058341T3 (es) 1994-11-01
ZA882407B (en) 1988-09-28
EP0294021A1 (en) 1988-12-07
IL85983A0 (en) 1988-09-30
JPH01502986A (ja) 1989-10-12
WO1988007863A1 (en) 1988-10-20
AU1702088A (en) 1988-11-04
JP2648951B2 (ja) 1997-09-03

Similar Documents

Publication Publication Date Title
EP0308500B1 (en) Human somatomedin carrier protein subunits and process for producing them
US5200509A (en) Human somatomedin carrier protein subunits and process for producing them; recombinant DNA molecules, hosts, processes and human somatomedin carrier protein-like polypeptides
Zapf et al. Serum levels of insulin-like growth factor (IGF) and its carrier protein in various metabolic disorders
CA2006322C (en) Recombinant dna molecules, hosts, processes and human somatomedin carrier protein-like polypeptides
Doneen et al. Studies on prolactin. Selective reduction of the disulfide bonds of the ovine hormone
JPH03506030A (ja) インスリン様成長因子（ｉｇｆ）結合蛋白複合体の酸不安定サブユニット（ａｌｓ）
JP2819467B2 (ja) 新規なカルジオジラチン断片およびその製造方法
BREUER Stimulation of DNA Synthesis in Cartilage of Modified Placental Lactogen and Anabolic Hormones
JP2527896B2 (ja) ヒト骨由来インスリン様成長因子結合タンパク
DEVITO Comparison of brain and pituitary immunoreactive prolactin by peptide mapping and lectin affinity chromatography
Robbins et al. Products of therapeutic insulins in the blood of insulin-dependent (type I) diabetic patients
WO2003102180A1 (fr) Nouveaux peptides avec activite de production de camp
JP2803184B2 (ja) 酸性線維芽細胞成長因子の抗体，その用途およびペプチド
Ooi et al. Recognition of insulin-like-growth-factor-binding proteins in serum and amniotic fluid by an antiserum against a low-molecular-mass insulin-like-growth-factor-inhibitor/binding protein
JP2562892B2 (ja) インスリン結合活性を有するポリペプチド
WO1996019501A1 (en) Modulators of bone cell function and uses thereof
HARTREE Chapter Preparation and 0ne Properties of Human Growth Hormone
Brems et al. Asp B1 insulin analogs